Skip to content
Nexus Surgical and Medicare logo

Nexus Surgical and Medicare

538874 BSE
₹20.14

Close ·

P/E
14.08
View as Markdown
MCP
Close 4 Nov 2026 ₹20.14 +2.40 +13.5% 1Y
Start ₹17.74

Key Fundamentals

MicrocapFinanceFinancial Services

Price-based figures at the close · EPS basis: Standalone · TTM

ROCE
69.90%
Debt to Equity
0.00
EPS (TTM)
₹1.43
Book Value
₹3.29
Market Cap
—
P/E (TTM)
14.08
P/B
6.12
ROE
51.80%
Dividend Yield
0.00%
EBITDA
₹1.00 Cr
52W High
₹35.79
52W Low
₹13.26

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

65 Good

Data confidence 94/100

Category scores

Quality
94
Strong
Returns, margins, earnings quality 22% weight
Valuation
47
Average
Cheap vs sector & own history 24% weight
Growth
75
Strong
Sales & profit trajectory 9% weight
Financial Health
73
Strong
Solvency, leverage, coverage 9% weight
Momentum
50
Average
Trend strength, vol-adjusted 12% weight
Ownership
50
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

2
  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 53.8%

Weaknesses

2
  • Stock is trading at 10.1 times its book value
  • Promoter holding is low: 18.7%

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1225
OscillatorsStrong Bullish225
Moving AveragesStrong Bearish1000

Key readings

RSI (14)
23.38
Bullish
MACD (12,26,9)
−2.62
Bearish
SMA (50)
27.97
Bearish
SMA (200)
21.20
Bearish

As of

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10Y+37.32%
5Y+16.04%
3Y+71.88%
1Y+37.59%
TTM+53.17%

Net profit

Net profit growth by window
10Y+30.93%
5Y+37.60%
3Y+63.28%
1Y+48.00%
TTM+39.29%

Operating cash flow

Operating cash flow growth by window
10YTurned positive
5Y−3.20%
3Y−32.39%
1Y+70.00%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y−11.91 pp
5Y+8.05 pp
3Y−1.86 pp
1Y+0.62 pp
TTM−1.65 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹0.30 Cr
Mar 2018₹0.98 Cr
Mar 2019₹2.14 Cr
Mar 2020₹1.73 Cr
Mar 2021₹3.74 Cr
Mar 2022₹2.40 Cr
Mar 2023₹1.55 Cr
Mar 2024₹3.47 Cr
Mar 2025₹5.72 Cr
Mar 2026₹7.87 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017−₹0.19 Cr
Mar 2018−₹0.33 Cr
Mar 2019−₹0.11 Cr
Mar 2020−₹5.30 Cr
Mar 2021₹0.15 Cr
Mar 2022₹0.29 Cr
Mar 2023₹0.17 Cr
Mar 2024₹0.21 Cr
Mar 2025₹0.50 Cr
Mar 2026₹0.74 Cr

Quarterly Results

₹ Cr
538874 quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
1.06
0.37
1.45
0.6
1.76
0.99
1.48
1.48
1.73
1.17
2.93
2.05
2.55
Expenses
1.03
0.28
1.4
0.52
1.64
0.71
1.33
1.37
1.53
0.94
2.71
1.75
2.31
Operating Profit
0.03
0.09
0.05
0.08
0.12
0.28
0.15
0.11
0.2
0.23
0.22
0.3
0.24
OPM %
2.83%
24.32%
3.45%
13.33%
6.82%
28.28%
10.14%
7.43%
11.56%
19.66%
7.51%
14.63%
9.41%
Other Income
0.01
0.02
0.01
0
0
0
0
0.01
0
0
0.01
0.02
0.03
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
PBT
0.04
0.11
0.06
0.08
0.12
0.28
0.15
0.12
0.2
0.23
0.23
0.32
0.27
Tax %
25%
27.27%
33.33%
25%
25%
25%
26.67%
25%
25%
26.09%
26.09%
25%
25.93%
Net Profit
0.03
0.08
0.05
0.06
0.09
0.21
0.11
0.09
0.15
0.17
0.17
0.24
0.2
EPS (₹)
0.05
0.15
0.09
0.11
0.16
0.38
0.2
0.16
0.27
0.31
0.31
0.44
0.37

Profit & Loss

₹ Cr
538874 profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
0.43
0.33
0.3
0.98
2.14
1.73
3.74
2.4
1.55
3.47
5.72
7.87
8.7
Expenses
0.21
0.25
0.48
1.36
2.32
1.66
3.58
2.03
1.33
3.2
5.05
6.9
7.71
Operating Profit
0.22
0.08
−0.18
−0.38
−0.18
0.07
0.16
0.37
0.22
0.27
0.67
0.97
0.99
OPM %
51.16%
24.24%
−60%
−38.78%
−8.41%
4.05%
4.28%
15.42%
14.19%
7.78%
11.71%
12.33%
11.38%
Other Income
0
0
0
0.06
0.08
−5.35
0.01
0.02
0.01
0.03
0.01
0.03
0.06
Interest
0
0.01
0.01
0
0
0
0
0
0
0.01
0.01
0.01
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
PBT
0.22
0.07
−0.19
−0.32
−0.1
−5.28
0.17
0.39
0.23
0.29
0.67
0.99
1.05
Tax %
31.82%
28.57%
0%
3.12%
0%
0.38%
5.88%
25.64%
26.09%
27.59%
25.37%
25.25%
—
Net Profit
0.15
0.05
−0.19
−0.33
−0.11
−5.3
0.15
0.29
0.17
0.21
0.5
0.74
0.78
EPS (₹)
0.27
0.09
−0.35
−0.6
−0.2
−9.69
0.27
0.53
0.31
0.38
0.91
1.35
1.43
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
538874 balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
5.47
5.47
5.47
5.47
5.47
5.47
5.47
5.47
5.47
5.47
5.47
5.47
Reserves
0.12
0.17
0
−0.33
−0.44
−5.73
−5.58
−5.29
−5.12
−4.91
−4.41
−3.67
Borrowings
0
0.09
0.29
0.25
0.26
0
0
0
0
0
0
0
Other Liabilities
0.13
0.04
0.18
0.2
0.2
0.47
1.04
1.82
0.56
1.25
1.21
1.85
Total Liabilities
5.72
5.77
5.94
5.59
5.49
0.21
0.93
2
0.91
1.81
2.27
3.65
Fixed Assets
0.03
0.03
0.03
0.02
0.02
0.02
0.02
0.01
0.02
0.02
0.02
0.02
CWIP
5.35
5.35
5.35
5.35
5.35
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
0.34
0.39
0.56
0.22
0.12
0.19
0.91
1.99
0.89
1.79
2.25
3.63
Total Assets
5.72
5.77
5.94
5.59
5.49
0.21
0.93
2
0.91
1.81
2.27
3.65

Cash Flow

₹ Cr
538874 cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0.03
−0.03
−0.17
−0.07
0.02
0.24
0.2
−0.11
0.55
−0.41
0.1
0.17
Investing
0
0
0
0
0
0
0
0
−0.01
0
−0.01
0
Financing
0
0.09
0.2
−0.04
0.01
−0.26
0
0
0
0
0
0
Net Cash Flow
0.03
0.05
0.03
−0.11
0.03
−0.02
0.2
−0.11
0.54
−0.42
0.1
0.17
Free Cash Flow
0.03
−0.03
−0.17
−0.07
0.02
0.24
0.2
−0.11
0.54
−0.41
0.09
0.17
CFO/OP
23
12
94
18
−11
343
125
−30
250
−152
15
18

Ratios

538874 financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
153
254
292
37.24
6.82
0
11.71
0
9.42
78.89
85.51
61.22
Inventory Days
—
156
138
15.21
0
0
0
—
56.78
243
83.93
55.35
Days Payable
—
104
227
72.24
—
—
—
—
454
754
230
239
Cash Conversion Cycle
153
307
204
−19.79
6.82
0
11.71
0
−388
−432
−60.88
−123
Working Capital Days
153
277
−73
−101
−66.52
−73.84
−43.92
−19.77
−77.71
29.45
44.67
58.9
ROCE %
3.96%
1.41%
−3.13%
−5.74%
−1.87%
2.78%
—
1114.29%
86.79%
65.93%
83.95%
69.93%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Nexus Surgical and Medicare insights

54 extracted metrics across FY10–FY27.

Shareholding Pattern

As of Sep 2026

  • Public 42.38%
  • Others 38.89%
  • Promoters 18.73%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Nexus Surgical and Medicare

What does Nexus Surgical and Medicare Ltd do?
Incorporated in 1992, Nexus Surgical and Medicare Ltd deals in medical disposable, surgical equipment, pharmaceutical products
Where is Nexus Surgical and Medicare Ltd (NEXUSSURGL) listed?
Nexus Surgical and Medicare Ltd trades under code 538874 on the BSE.
Which sector does Nexus Surgical and Medicare Ltd belong to?
Nexus Surgical and Medicare Ltd is classified under the Financial Services sector, in the Other Financial Services industry.
What is the PE ratio of Nexus Surgical and Medicare Ltd?
Nexus Surgical and Medicare Ltd trades at a PE ratio of 14.08 as of 4 Nov 2026, on earnings per share of ₹1.43, against a book value of ₹3.29 per share.
What is the 52-week high and low of Nexus Surgical and Medicare Ltd?
Over the last 52 weeks Nexus Surgical and Medicare Ltd has traded between ₹13.26 and ₹35.79 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Nexus Surgical and Medicare Ltd?
Nexus Surgical and Medicare Ltd reported a return on equity of 51.80%. Its debt-to-equity ratio is 0.00.

Company Information

Incorporated in 1992, Nexus Surgical and Medicare Ltd deals in medical disposable, surgical equipment, pharmaceutical products

Website nexusmed.co.in
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/538874.md for Nexus Surgical and Medicare Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More NBFC & Finance stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month